Correspondence 0001104659-23-004263 from American Oncology Network, Inc. (AONC, AONCW) (CIK 0001839998)
American Oncology Network, Inc. (AONC, AONCW) (CIK 0001839998)
Date: Jan. 17, 2023 · CIK: 0001839998 · Accession: 0001104659-23-004263
AI Filing Summary & Sentiment
Reasoning
Letter
Re: Digital Transformation Opportunities Corp.
January 17, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Preliminary Proxy Statement
Ladies and Gentlemen:
On behalf of our client, Digital Transformation Opportunities Corp. (the “Company”), the Company is filing with the Securities and Exchange Commission a preliminary proxy statement relating to the Company’s special meeting (the “Proxy Statement”).
Please contact Jonathan Ko of Paul Hastings LLP, counsel to the Company, by phone at (213) 683-6188 or by email at jonathanko@paulhastings.com regarding the Proxy Statement.
Very truly yours,
Jonathan Ko
Show Raw Text
CORRESP
1
filename1.htm
January 17, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Digital Transformation Opportunities
Corp.
Preliminary Proxy Statement
Ladies and Gentlemen:
On behalf
of our client, Digital Transformation Opportunities Corp. (the “Company”), the Company is filing with the Securities and Exchange
Commission a preliminary proxy statement relating to the Company’s special meeting (the “Proxy Statement”).
Please contact Jonathan Ko of Paul Hastings LLP,
counsel to the Company, by phone at (213) 683-6188 or by email at jonathanko@paulhastings.com regarding the Proxy Statement.
Very truly yours,
Jonathan Ko
Paul Hastings LLP
cc: Kevin Nazemi, Digital Transformation
Opportunities Corp.
David Gould, American Oncology Network, LLC
David Hernand, Paul Hastings LLP
Sahand Moarefy, Paul Hastings LLP
Brian Lee, Dentons US LLP
Ilan Katz, Dentons US LLP